| Applicable regulations and market requirements | Confirm which countries and product uses the gelatin will serve, and identify the applicable regulatory and customer requirements for each destination market. | Written regulatory-support statement, product specifications, and a documented assessment mapping the material to the intended markets and use. | Check that the supplier’s claims are specific to the material, manufacturing site, intended use, and destination market—not presented as universal approval. |
| Pharmacopoeial conformity | Determine whether the material must comply with a relevant gelatin monograph, such as the applicable USP–NF or European Pharmacopoeia requirements. | Current specification, representative certificate of analysis, analytical methods, and evidence that test methods and limits correspond to the required edition and market. | Compare the specification and test results with the requirements that apply to your product. Pharmacopoeial compliance does not, by itself, qualify a supplier. |
| Good manufacturing practices for excipients | Assess whether the supplier operates controls appropriate for a pharmaceutical excipient, including documented procedures, trained personnel, sanitation, production controls, and quality oversight. | Quality-system overview, applicable excipient GMP certificate or audit report, certificate scope, covered site, validity dates, and any corrective-action follow-up. | Verify the certificate with its issuer and confirm that it covers the actual manufacturing site and relevant activities. A certificate should not be treated as a substitute for risk-based qualification. |
| Quality management system | Review controls for document management, deviations, investigations, corrective and preventive actions (CAPA), change control, complaints, and product release. | Quality manual or system summary, relevant procedures, anonymized examples of deviation and CAPA records, and change-notification commitments. | Look for documented responsibilities, timely investigations, effectiveness checks, and advance notification of changes that could affect material quality or regulatory status. |
| Testing, specifications, and certificates of analysis | Confirm that each lot is tested against approved specifications using suitable methods, with clear acceptance criteria and traceable results. | Sample lot-specific certificate of analysis, test-method references, laboratory controls, and an explanation of any tests performed by external laboratories. | Check that results are numeric where appropriate, units are clear, and the certificate identifies the lot and specification revision. Confirm which tests are performed for every lot. |
| Data integrity and record retention | Assess whether quality and laboratory records are attributable, legible, contemporaneous, original or true copies, accurate, complete, and protected from unauthorized changes. | Data-integrity policy, access-control and audit-trail practices for electronic records, backup procedures, and record-retention policy. | Verify that records supporting manufacture, testing, release, and traceability can be retrieved for the period required by applicable rules and agreements. |
| Animal-source controls and traceability | Establish the gelatin’s animal species, source material, country or countries of origin, and traceability through relevant manufacturing stages. Evaluate transmissible spongiform encephalopathy (TSE/BSE) risks where applicable. | Origin and traceability statement, source-material controls, applicable TSE/BSE risk documentation, and procedures for changes to species or origin. | Match source information and risk documentation to the intended market and product requirements. Confirm that changes to animal source or origin require notification and assessment. |
| Manufacturing-site audit and supplier qualification | Qualify the actual manufacturing site, not only a sales or distribution office. Use a risk-based assessment and determine whether an on-site or independent audit is warranted. | Site questionnaire, recent audit report or audit summary, site address, scope of operations, and documented responses to audit findings. | Review findings, their risk classification, corrective actions, and closure evidence. Reassess the supplier periodically and when significant changes occur. |
| Regulatory registrations and submissions | Clarify the status and purpose of any regulatory registration, listing, or dossier reference cited by the supplier, and whether it covers the relevant site and material. | Official status information or authorized supporting documentation, plus a description of the submission’s scope and the supplier’s authorization to share relevant information. | Do not interpret a facility registration or a voluntary dossier submission as regulatory approval or endorsement of a particular product. |
| Ongoing compliance and communication | Confirm how the supplier communicates regulatory updates, inspection outcomes where shareable, significant quality events, and changes that may affect supply or compliance. | Quality agreement, change-control procedure, escalation contacts, notification timelines, and business-continuity or supply-contingency information. | Document responsibilities and notification expectations before purchase. Ensure changes are reviewed and approved through your own quality system before implementation. |